FXIA INHIBITORS AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

WIPO Patent Application WO/2021/057818

A1

Provided in the present invention is a series of selective Factor XIa (FXIa) inhibitors, relating to the technical field of chemical drugs. The present invention also relates to pharmaceutical compositions containing said compounds and a use of said compounds in drugs for the treatment of diseases such as thromboembolism.

WU JUNJUN (CN)
LU YINSUO (CN)
XIAO YING (CN)
HONG ZEXIN (CN)
WU JIANLI (CN)
XING WEI (CN)

PCT/CN2020/117257

April 01, 2021

September 24, 2020

Click for automatic bibliography generation  

SHENZHEN SALUBRIS PHARM CO LTD (CN)

C07D401/14; A61K31/395; A61K31/495; A61K31/501; A61P7/02; A61P9/10; C07D401/10; C07D401/12

WO2018041122A1	2018-03-08
WO1996030396A1	1996-10-03
WO1999041276A1	1999-08-19
WO2013093484A1	2013-06-27
WO2004002405A2	2004-01-08
WO2013056060A1	2013-04-18
WO2017005725A1	2017-01-12
WO2017023992A1	2017-02-09
WO2018041122A1	2018-03-08

CN108137549A	2018-06-08
CN107793396A	2018-03-13
US20170291892A1	2017-10-12
GB2497806A	2013-06-26

N ENGL J MED, vol. 325, 1991, pages 153 - 8
BLOOD., vol. 101, 2003, pages 4783 - 4788
BLOOD., vol. 116, no. 19, 2010, pages 3981 - 3989
BLOOD, vol. 114, 2009, pages 2878 - 2883
THROMB HAEMOST, vol. 105, 2011, pages 269 - 273
"Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT, WILLIAMS & WILKINS
ANGEWANDTE CHEMIE, vol. 49, no. 46, 2010, pages 8729 - 8732
See also references of EP 4036087A4

View/Download PDF      PDF Help

Previous Patent: HIS-MBP TAGGED DNA ENDONUCLEASE FOR FACILITATED ENZYME REMOVAL

Next Patent: APPARATUS AND METHOD USED FOR MODE SWITCHING, AND ELECTRONIC DEVICE